• HIDEN, IMP1, and FZD5 in Endoderm Differentiation

  2026-08-27

  Lu et al. identify HIDEN as a gene-desert lncRNA that promotes human definitive endoderm differentiation by helping IMP1 stabilize FZD5 mRNA and sustain WNT signaling. The study provides a mechanistic framework for investigating distal lncRNAs and offers a useful design model for combining stage-specific profiling, genetic perturbation, RNA–protein analysis, and pathway rescue.

• Podophyllotoxin Workflows for Cancer Cell Studies

  2026-08-27

  Build reproducible cancer-cell assays around Podophyllotoxin’s microtubule-directed mitotic arrest, while separating parent-compound effects from derivative-specific mechanisms. This workflow covers stock preparation, cell-cycle and apoptosis readouts, autophagy controls, multidrug-resistance models, and practical troubleshooting.

• IPA-3 Workflows for Pak1 Signaling Research

  2026-08-26

  IPA-3 is a non-ATP-competitive tool for separating group I Pak regulatory signaling from conventional ATP-site effects. This guide translates its biochemical, cellular, neuroinflammation, and viral-entry use cases into practical workflows with concentration planning, controls, and troubleshooting advice.

• Angiotensin (1-7): From Peptide Identity to Assay Logic

  2026-08-26

  Angiotensin (1-7) research is often framed around Mas receptor biology, but its analytical identity is equally important. This article connects peptide sequence, ACE2 substrate behavior, pathway interpretation, and model selection to improve mechanistic study design.

• ECL Chemiluminescent Substrate Detection Kit for RCC

  2026-08-25

  The ECL Chemiluminescent Substrate Detection Kit supports sensitive, decision-oriented western blot analysis of albiflorin-responsive renal cell carcinoma signaling. This article connects assay chemistry with phospho-protein interpretation, exposure strategy, and the integrated experimental design reported in the latest RCC study.

• Norovirus Co-opts NINJ1 for Selective Secretion

  2026-08-25

  Song and colleagues show that murine norovirus repurposes the cell-death effector NINJ1 to release the viral NS1 protein through an unconventional secretion pathway. The study combines CRISPR screening, genetic and pharmacological perturbation, protein interaction analysis, mutagenesis, imaging, and mouse infection models to connect caspase-3 activation, NINJ1 oligomerization, and viral immune evasion.

• Baicalein N1858 for Reproducible Cell Assays

  2026-08-24

  Learn how Baicalein (SKU N1858) can improve solvent control, assay design, compound handling, and interpretation in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects product specifications with practical laboratory decisions while distinguishing established evidence from workflow recommendations.

• Cediranib (AZD2171) In Vitro Workflows

  2026-08-23

  Build more informative angiogenesis experiments with Cediranib (AZD2171) by separating pathway suppression, growth inhibition, and actual cell killing. This practical workflow combines VEGFR signaling assays with orthogonal viability and death measurements to improve interpretation in cancer research.

• Cholesterol B1702 for Reliable Cell Assays

  2026-08-22

  This scenario-based guide explains how Cholesterol (SKU B1702) can improve control of membrane, viability, proliferation, and lipid nanoparticle workflows. It links solvent handling, molar normalization, assay controls, and interpretation to current evidence from localized p21 mRNA–LNP research.

• H 89 2HCl in Osteoclast cAMP/PKA Assays

  2026-08-21

  H 89 2HCl provides a practical pharmacological way to test whether dopamine-regulated osteoclastogenesis depends on PKA downstream of cAMP production. This guide translates the reference pathway into dose-controlled workflows, rescue experiments, phosphorylation readouts, and troubleshooting strategies that account for H-89’s broader kinase activity at higher concentrations.

• PF-573228: A Matrix-Aware FAK Inhibitor Guide

  2026-08-20

  PF-573228 is an ATP-competitive FAK inhibitor for dissecting adhesion, mechanotransduction, angiogenesis, and tumor-cell behavior. This guide adds a matrix-aware assay framework that separates FAK pathway effects from substrate and cytotoxicity confounders.

• NETs in CML and Their TKI-Dependent Regulation

  2026-08-20

  The reference study shows that neutrophil extracellular trap formation is elevated in chronic myeloid leukemia and is differentially altered by tyrosine kinase inhibitors, with ponatinib producing the strongest NET-associated response. Patient-derived neutrophils and a BCR-ABL1-transduced HoxB8 model connect these observations to PAD4-dependent histone citrullination and provide a framework for investigating vascular toxicity in CML.

• 4-Hydroxytamoxifen: Protocol and QC Guide

  2026-08-19

  4-Hydroxytamoxifen is a DMSO-compatible estrogen receptor modulator for controlled receptor studies, including breast cancer research, prostate cancer research, and cardiac myocyte workflows. It is not suitable for protocols that require direct water- or ethanol-based preparation, and long-term storage of solution should be avoided.

• PAD4-IN-2 TFA: Tumor-Targeted Workflow

  2026-08-19

  PAD4-IN-2 TFA, also known as Compound 5i TFA, connects tumor-biased uptake with suppression of the PAD4–H3cit–NET axis. This practical guide shows how to evaluate its effects on tumor-cell migration, neutrophil biology, metastasis, and the tumor immune microenvironment while avoiding common assay artifacts.

• ETS1–SENP2 Axis Restrains Mitophagy in BPD

  2026-08-18

  The reference study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-induced bronchopulmonary dysplasia by activating SENP2 and coordinating FUNDC1 deSUMOylation, HSPA8 binding, and FUNDC1 degradation. Its cell and mouse experiments connect SUMO1 modification with mitochondrial quality control, while also highlighting the need for further validation before translation to clinical BPD treatment.

458 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page